Therapy Areas: Central Nervous System
19 November 2019 - BioArctic AB (STO: BIOAB), a Swedish research-based biopharmaceutical company, reported on Monday the results of an interim analysis of a phase 1/2 study of SC0806 in patients with ...
13 November 2019 - - US-based biotechnology company Genentech has released positive data from the pivotal Part 2 of the SUNFISH study evaluating risdiplam in people aged 2-25 years with Type 2 or 3 sp...
13 November 2019 - Switzerland-based Roche has met its primary endpoint in part two of the SUNFISH trial evaluating Risdiplam intended for the treatment of Type 2 or 3 spinal muscular atrophy in peopl...
6 November 2019 - - US-based biopharmaceutical company Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) has appointed Ponni Subbiah, M.D., M.P.H., as senior vice president, global head of medical affairs an...
1 November 2019 - ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialisation of innovative medicines to address unmet medical needs in central nervous system ...
31 October 2019 - - UK-based biotechnology company Bicycle Therapeutics plc (NASDAQ: BCYC) has appointed Nigel Crockett, Ph.D., as the company's chief business officer, replacing Peter Leone...
Related Headlines